ライフサイエンスコーパス: endothelial progenitor

1 fferentiation, and molecular profiling of an endothelial progenitor.

2 l that originates in bone marrow, a putative endothelial progenitor.

3 NOTCH1 silencing blocks the transition into endothelial progenitors.

4 lay a crucial role in the differentiation of endothelial progenitors.

5 initive hematopoietic progenitors as well as endothelial progenitors.

6 ic stem cells, mesenchymal stromal cells and endothelial progenitors.

7 s that did not receive MFSD2A-overexpressing endothelial progenitors.

8 proposal suggests that neovessels form from endothelial progenitors able to assemble the intimal lay

9 xpressed markers consistent with circulating endothelial progenitors and synthesized high levels of p

10 venous capillary ECs and respective resident endothelial progenitors appear to be at the origin of CC

11 ecified in the somite at forelimb level, but endothelial progenitors are absent.

12 Myo-endothelial progenitors are the most affected cell type:

13 xpressing cells that show characteristics of endothelial progenitors capable of maturation into endot

14 PCs with osteogenic properties carrying both endothelial progenitor (CD34, KDR) and osteoblastic (ost

15 n in primary tumors, including expression of endothelial progenitor cell (CD133 and CD34) and endothe

16 n of ADAM17, modulates postnatal circulating endothelial progenitor cell (CEPC) numbers via effects o

17 ation system can detect endothelial cell and endothelial progenitor cell (EPC) activation in vitro an

18 w PA diabetic (d-PA) concentrations affected endothelial progenitor cell (EPC) and bone marrow-derive

19 ion compromises the reparative properties of endothelial progenitor cell (EPC) and their exosomes on

20 Endothelial progenitor cell (EPC) counts are proposed su

21 regard to endothelial vasodilatory function, endothelial progenitor cell (EPC) function, in vivo neoa

22 y increased vascular senescence and impaired endothelial progenitor cell (EPC) function.

23 number and impaired physiology of endogenous endothelial progenitor cell (EPC) population that limits

24 ine human microvascular EC (HMVEC) and human endothelial progenitor cell (EPC) recruitment into engra

25 wound closure rates, neovascularization, and endothelial progenitor cell (EPC) recruitment.

26 cumented the role of SIRT1 in reduced EC and endothelial progenitor cell (EPC) viability.

27 h-mobility-group-box-1 (HMGB1) that promotes endothelial progenitor cell (EPC)-mediated neurovascular

28 impaired Lin(-)cKit(+)Sca1(+) (LKS) cell and endothelial progenitor cell (EPC; CD34(+)Flk1(+)) mobili

29 mal cell sheets (hMSC) as the wall and human endothelial progenitor cell (hEPC) coating as the lumen.

30 tem that sustains the release of a bioactive endothelial progenitor cell chemokine during a 4-week pe

31 eeks in vitro, remained active, and enhanced endothelial progenitor cell chemotaxis.

32 t peripheral blood (PB) cytokines predict BM endothelial progenitor cell colony outgrowth and cardiac

33 y safety and primary efficacy end points and endothelial progenitor cell colony-forming unit mobiliza

34 There was robust endothelial progenitor cell colony-forming unit mobiliza

35 exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be ident

36 ent vasorelaxation of thoracic aortas and in endothelial progenitor cell function, as assessed by the

37 tric oxide (NO) is a key regulator of EC and endothelial progenitor cell function, but the pathophysi

38 e haemoglobin and modulates inflammation and endothelial progenitor cell function.

39 release of SDF-1, a chemokine that promotes endothelial progenitor cell homing and angiogenesis, fro

40 Since the identification of the endothelial progenitor cell in 1997 by Asahara and Isner

41 sFlt1 with concomitant decreased circulating endothelial progenitor cell levels along with inappropri

42 Baseline flow-mediated dilation and endothelial progenitor cell levels were lower in patient

43 Circulating endothelial progenitor cell levels were quantified to as

44 loading promoted osteoblast differentiation, endothelial progenitor cell migration, and tube formatio

45 roliferative capacity of ECs and circulating endothelial progenitor cell numbers after vascular injur

46 glitazone in improving endothelial function, endothelial progenitor cell numbers and functional capac

47 d Notch signaling increased Prox1+ lymphatic endothelial progenitor cell numbers in the veins, leadin

48 under oxidative stress, as well as decreased endothelial progenitor cell numbers were responsible for

49 and significantly increased Prox1+ lymphatic endothelial progenitor cell numbers.

50 Participants underwent endothelial progenitor cell phenotyping with an early-ou

51 Multicolor flow cytometry quantified the endothelial progenitor cell population in the bone marro

52 further enriched by selection for a CD133(+) endothelial progenitor cell population.

53 The endothelial progenitor cell recently emerged as an impor

54 g tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not res

55 ), and group 5 (combined bone marrow-derived endothelial progenitor cell-extracorporeal shock wave) a

56 present study suggests that ischemia-induced endothelial progenitor cell-mediated neovascularization

57 ently, it remains controversial how vascular endothelial progenitor cells (angioblasts) establish the

58 We discovered that bone marrow-derived endothelial progenitor cells (BM-EPC), having the phenot

59 ating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs).

60 Circulating endothelial progenitor cells (cEPCs) are known to contri

61 more, conditioned medium (CM) from embryonic endothelial progenitor cells (eEPCs) rescued the follicu

62 ndothelial cells, thus tethering circulating endothelial progenitor cells (EPC) and facilitating homi

63 Endothelial progenitor cells (EPC) are able to migrate t

64 Bone marrow-derived endothelial progenitor cells (EPC) contribute to the ang

65 s (GSKi) can improve therapeutic efficacy of endothelial progenitor cells (EPC) from patients with DM

66 derived from the intended recipient--either endothelial progenitor cells (EPC) or endothelial cell (

67 (SDF-1alpha, a homing signal for recruiting endothelial progenitor cells (EPC) to areas of neovascul

68 Homing of endothelial progenitor cells (EPC) to the ischemic tissu

69 Endothelial progenitor cells (EPC) were successfully cul

70 angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC).

71 d cancer progression for bone marrow-derived endothelial progenitor cells (EPC).

72 otransplantation of peripheral blood-derived endothelial progenitor cells (EPCs) and bone marrow-deri

73 Herein, mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs) and c-Kit(+) cardiac

74 to impairments in vascular repair induced by endothelial progenitor cells (EPCs) and circulating angi

75 s were supported by in vitro observations on endothelial progenitor cells (EPCs) and endothelial cell

76 tified endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs) and evaluated, in 24

77 and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angioge

78 ll apoptosis and vascular repair mediated by endothelial progenitor cells (EPCs) and myeloid circulat

79 The number of circulating endothelial progenitor cells (EPCs) and plasma levels of

80 ed the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from n

81 Endothelial progenitor cells (EPCs) are a heterogeneous

82 l cells, and form new vessels, blood-derived endothelial progenitor cells (EPCs) are attractive sourc

83 rculating progenitor cells (CPCs), including endothelial progenitor cells (EPCs) are biologically rel

84 Endothelial progenitor cells (EPCs) are decreased in num

85 Endothelial progenitor cells (EPCs) are essential in vas

86 Mobilization and functions of endothelial progenitor cells (EPCs) are increased in pat

87 Endothelial progenitor cells (EPCs) are known to promote

88 Endothelial progenitor cells (EPCs) are present in the s

89 Diverse subsets of endothelial progenitor cells (EPCs) are used for the tre

90 stasis, we identify bone marrow (BM)-derived endothelial progenitor cells (EPCs) as critical regulato

91 ct MVs shed from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbe

92 ic platform capable of capturing circulating endothelial progenitor cells (EPCs) by understanding sur

93 by extracellular matrix scaffold seeded with endothelial progenitor cells (EPCs) can overcome these l

94 Endothelial progenitor cells (EPCs) can participate with

95 Endothelial progenitor cells (EPCs) contribute to postna

96 Endothelial progenitor cells (EPCs) contribute to vascul

97 etic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly

98 D133(+) and CD34(+) CPCs as well as cultured endothelial progenitor cells (EPCs) derived from blood m

99 Endothelial progenitor cells (EPCs) enter the systemic c

100 therosclerosis have increases in circulating endothelial progenitor cells (EPCs) expressing an osteog

101 We have previously shown that human endothelial progenitor cells (EPCs) form functioning ves

102 infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow

103 n in the control of regenerative function of endothelial progenitor cells (EPCs) has not been studied

104 Reduced levels of endothelial progenitor cells (EPCs) have been associated

105 Endothelial progenitor cells (EPCs) have been associated

106 Although different substances that mobilize endothelial progenitor cells (EPCs) have been proposed,

107 Endothelial progenitor cells (EPCs) have been shown to a

108 Little is known about the role of endothelial progenitor cells (EPCs) in atherosclerosis.

109 Endothelial progenitor cells (EPCs) in ESA gradient, ass

110 The discovery of endothelial progenitor cells (EPCs) in human peripheral

111 ggest a critical role of bone marrow-derived endothelial progenitor cells (EPCs) in neovascularizatio

112 Diabetic individuals have fewer endothelial progenitor cells (EPCs) in their circulation

113 Migration of endothelial progenitor cells (EPCs) into areas of vascul

114 The incorporation of endothelial progenitor cells (EPCs) into microvessels co

115 The incorporation of endothelial progenitor cells (EPCs) into newly developin

116 Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging conce

117 Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging thera

118 Vascular repair by marrow-derived endothelial progenitor cells (EPCs) is impaired during d

119 d on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known.

120 Endothelial progenitor cells (EPCs) may be relevant cont

121 Endothelial progenitor cells (EPCs) normally augment ang

122 (SHS) exposure on the number and function of endothelial progenitor cells (EPCs) over 24 h.

123 In adults, circulating endothelial progenitor cells (EPCs) participate in vascu

124 Endothelial progenitor cells (EPCs) play a critical role

125 Endothelial progenitor cells (EPCs) play an important ro

126 Endothelial progenitor cells (EPCs) promote neovasculari

127 and circulating progenitor cells (CPCs) and endothelial progenitor cells (EPCs) PTH, and genetic par

128 Late outgrowth endothelial progenitor cells (EPCs) represent a promisin

129 only isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion t

130 n (TBI) and then infused with C57Bl6-derived endothelial progenitor cells (EPCs) to augment endogenou

131 Endothelial progenitor cells (EPCs) was assayed by flow

132 Endothelial progenitor cells (EPCs) were cultured on the

133 carotid arteries and circulating numbers of endothelial progenitor cells (EPCs) were examined after

134 Circulating endothelial progenitor cells (EPCs) were quantified at b

135 e number of bone marrow and peripheral blood endothelial progenitor cells (EPCs), a marker of vascula

136 Flow cytometry was applied to quantify endothelial progenitor cells (EPCs), circulating endothe

137 Endothelial progenitor cells (EPCs), critical for mediat

138 Endothelial progenitor cells (EPCs), defined as CD34(+)V

139 We hypothesized that adriamycin affects endothelial progenitor cells (EPCs), leading to impaired

140 at PAH patients are deficient in circulating endothelial progenitor cells (EPCs), potentially contrib

141 nclude endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs), respectively.

142 Since the discovery of endothelial progenitor cells (EPCs), there have been con

143 the mobilization of bone marrow (BM)-derived endothelial progenitor cells (EPCs), thereby enhancing n

144 is associated with a deficit of circulating endothelial progenitor cells (EPCs), which has been attr

145 have profound effects on the endothelium and endothelial progenitor cells (EPCs), which originate fro

146 etic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain

147 eovascularization is controversial, but BMD--endothelial progenitor cells (EPCs)--are strongly implic

148 repair by regenerative endothelial cells and endothelial progenitor cells (EPCs).

149 cells (CECs), angiogenic growth factors, and endothelial progenitor cells (EPCs).

150 e-induced recruitment of bone marrow-derived endothelial progenitor cells (EPCs).

151 Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs).

152 ish the effects of human bone marrow-derived endothelial progenitor cells (hBMEPCs) systemically tran

153 layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPCs) from a separate,

154 Human endothelial progenitor cells (hEPCs) participate in neov

155 ylation in cord blood-derived late outgrowth endothelial progenitor cells (OEPCs).

156 Endometriotic lesions increased circulating endothelial progenitor cells 13 days after engraftment,

157 eated with intramuscular bone marrow-derived endothelial progenitor cells [2.0 x 10 cells]), group 4

158 e of a role for bone marrow-derived putative endothelial progenitor cells after iatrogenic vascular i

159 to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribron

160 ntly increased numbers of VEGFR2(+)/AC133(+) endothelial progenitor cells and CD34(+)/VEGFR1(+) hemat

161 Combined treatment with bone marrow-derived endothelial progenitor cells and extracorporeal shock wa

162 hips, which expands their endogenous pool of endothelial progenitor cells and generates vascular netw

163 Next, resident endothelial progenitor cells and hematopoietic stem cell

164 Exogenous uric acid rapidly mobilizes endothelial progenitor cells and hematopoietic stem cell

165 l plaque volume but does stabilize levels of endothelial progenitor cells and improve microvascular f

166 r analog [ESA]) induces continuous homing of endothelial progenitor cells and improves left ventricul

167 nrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnata

168 actor-1 (SDF-1) is a chemokine that attracts endothelial progenitor cells and promotes angiogenesis.

169 IL-1beta and IL-18, and coadministration of endothelial progenitor cells and stromal cell-derived fa

170 stigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic

171 s process is recapitulated in the adult when endothelial progenitor cells are generated in the bone m

172 or cells, rhG-CSF can mobilize dendritic and endothelial progenitor cells as well.

173 rentiated them to both endothelial cells and endothelial progenitor cells by using the embryoid body

174 Endothelial progenitor cells can restore vessel wall fun

175 forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis i

176 Endothelial progenitor cells contribute to vascular repa

177 Endothelial/endothelial progenitor cells derived from iPS cells expr

178 etwork mediating developmental plasticity of endothelial progenitor cells during embryonic developmen

179 During embryogenesis, lymphatic endothelial progenitor cells first arise from a subset o

180 we demonstrate the isolation of CD34+/Flk1+ endothelial progenitor cells from blood enabled by the d

181 ing mature endothelial cells and circulating endothelial progenitor cells from septic shock and nonse

182 ically engineered mesenchymal stem cells and endothelial progenitor cells has been explored as a rege

183 e assessed at multiple time points using rat endothelial progenitor cells in a transwell migration as

184 mor progression have 2-fold more circulating endothelial progenitor cells in peripheral blood than co

185 tometry was performed to measure circulating endothelial progenitor cells in peripheral blood.

186 The miR array data from endothelial progenitor cells in response to inflammatory

187 is expressed in tumor neovasculature and on endothelial progenitor cells in the bone marrow, was lab

188 , exhibited an increased number of lymphatic endothelial progenitor cells in the cardinal veins, toge

189 ining the role of murine bone marrow-derived endothelial progenitor cells in the process of tumor neo

190 This correlated with a 30% increase in endothelial progenitor cells in the retina at postnatal

191 By contrasting the role of endothelial progenitor cells in tissue regeneration with

192 lary density, as well as bone marrow-derived endothelial progenitor cells incorporation into the func

193 ance by CYP26B1 in the vicinity of lymphatic endothelial progenitor cells is important for determinin

194 Late outgrowth endothelial progenitor cells isolated from HPAH patients

195 Further evidence suggests that stem cells or endothelial progenitor cells may be released from both b

196 vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proathero

197 corporeal shock wave and bone marrow-derived endothelial progenitor cells might exert enhanced protec

198 mation of a vascular network from individual endothelial progenitor cells occurring during embryonic

199 ECs expanded from blood-derived endothelial progenitor cells of VWD patients confirmed t

200 ve is superior to either bone marrow-derived endothelial progenitor cells or extracorporeal shock wav

201 eproduced in vitro by incubation of cultured endothelial progenitor cells or spleen-derived endotheli

202 Delivery of endothelial progenitor cells overexpressing endothelial

203 To clarify the origin of endothelial progenitor cells participating in endothelia

204 Putative endothelial progenitor cells play a role in organ regene

205 ng living individuals, and its knock-down in endothelial progenitor cells precludes their capacity to

206 e enhancer identified here becomes active in endothelial progenitor cells shortly after their initial

207 ain reaction and generated higher numbers of endothelial progenitor cells than CD31(-) cells did.

208 s study provides strong evidence in neonatal endothelial progenitor cells that GDM exposure in utero

209 abolites by gut endothelium requires MFSD2A; endothelial progenitor cells that overexpress MFSD2A red

210 Human circulating endothelial progenitor cells that overexpress MFSD2A wer

211 In mice with colitis, transplanted endothelial progenitor cells that overexpressed MFSD2A n

212 d (EECM), which differentiates hiPSC-derived endothelial progenitor cells to brain microvascular endo

213 The contribution of bone marrow (BM) endothelial progenitor cells to capillarization was iden

214 ls of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into matur

215 essed by the capacity of bone marrow-derived endothelial progenitor cells to differentiate into matur

216 en restored the resistance of both BMDCs and endothelial progenitor cells to oxidative stress, improv

217 ineered vessel can be seeded with autologous endothelial progenitor cells to provide a biological vas

218 igration of green fluorescent protein-tagged endothelial progenitor cells to tumor tissues.

219 Enhanced apoptosis of endothelial progenitor cells under oxidative stress, as

220 ized green fluorescent protein-Tie2-positive endothelial progenitor cells versus controls, with a cor

221 The Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

222 with CLI (n=33) included in the Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

223 flammatory stimuli, the miR array profile of endothelial progenitor cells was analyzed using a polyme

224 Endothelial progenitor cells were CD31+, vWF+, and alpha

225 Endothelial progenitor cells were not observed along the

226 The implanted endothelial progenitor cells were restricted to the lumi

227 uch a lentiviral vector can be used to endow endothelial progenitor cells with anti-tumor properties.

228 udy was to determine the role of circulating endothelial progenitor cells with osteoblastic phenotype

229 us mechanism of Hh signaling in angioblasts (endothelial progenitor cells) during arterial-venous spe

230 icity of cardiac fibroblasts and circulating endothelial progenitor cells, and consider what role the

231 ty over the precise identity and function of endothelial progenitor cells, and harnessing their thera

232 es consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells

233 Signaling between endothelial cells, endothelial progenitor cells, and stromal cells is cruci

234 The CACs, also termed endothelial progenitor cells, are critical for vascular

235 Endothelial progenitor cells, as well as HSC/HPCs, were

236 ndothelial nitric oxide synthase-transfected endothelial progenitor cells, divided into 3 doses on co

237 bone marrow-derived cell populations, called endothelial progenitor cells, have been reported to poss

238 the differentiation capacity of bone marrow endothelial progenitor cells, improved endothelium-depen

239 g promotes differentiation and maturation of endothelial progenitor cells, its role in the differenti

240 However, in contrast to endothelial progenitor cells, mature LSECs express littl

241 ecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular

242 ypes, including hematopoietic stem cells and endothelial progenitor cells, more efficiently than the

243 such as peripheral hematopoietic stem cells, endothelial progenitor cells, or circulating tumor cells

244 ematopoietic stem cells and depleted splenic endothelial progenitor cells, partially reproducing the

245 Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and M

246 pecimen was performed for endothelial cells, endothelial progenitor cells, smooth muscle cells, and i

247 study of the tolerability of culture-derived endothelial progenitor cells, transiently transfected wi

248 including RhoA/Rho kinase, tyrosine kinase, endothelial progenitor cells, vasoactive intestinal pept

249 homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis,

250 e that hematopoietic tissues are a source of endothelial progenitor cells, which contribute to newly

251 ed cellularity and altered the phenotypes of endothelial progenitor cells, which resulted in changes

252 ncy is associated with decreased circulating endothelial progenitor cells-like CD31(+)/c-Kit(+) cells

253 ability to differentiate into erythroid and endothelial progenitor cells.

254 linase in microparticle-induced apoptosis of endothelial progenitor cells.

255 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

256 lial marker CD31, suggesting the presence of endothelial progenitor cells.

257 in these hematopoietic tissues gives rise to endothelial progenitor cells.

258 epletion restores the functional capacity of endothelial progenitor cells.

259 It has also been used to identify endothelial progenitor cells.

260 associated with mobilization of circulating endothelial progenitor cells.

261 nhance the benefit of stem cell therapy with endothelial progenitor cells.

262 t abnormalities in phenotype and function of endothelial progenitor cells.

263 f promoting endothelial regeneration through endothelial progenitor cells.

264 th tumor endothelial and bone marrow-derived endothelial progenitor cells.

265 cripts in ischemic tissue and in circulating endothelial progenitor cells.

266 ng a mixture of cardiac progenitor cells and endothelial progenitor cells.

267 of edema, and depletion of regulatory T and endothelial progenitor cells.

268 sources, including bone marrow (circulating endothelial progenitors; CEP), and established vasculatu

269 profiles in the CD133(+) tumour cells, their endothelial progenitor derivatives and mature endotheliu

270 r importance is TLR4-mediated recruitment of endothelial progenitors derived from immature myeloid ce

271 ces are identified in a GSK3 inhibitor based endothelial progenitor differentiation protocol.

272 treated with VEGF during the second stage of endothelial progenitor differentiation.

273 rns the specification of the earliest hemato-endothelial progenitors during embryogenesis.

274 r, we demonstrate that Notch is activated in endothelial progenitors during vasculogenesis prior to b

275 ted receptors and alphaVbeta3-overexpressing endothelial progenitor EP cells) and the kinase inhibito

276 tracellular matrix compartment and recruited endothelial progenitors for neovascularization.

277 g might play an important role in specifying endothelial progenitors from the mesoderm, given that th

278 artery pressure, whereas levels of resident endothelial progenitors in IPAH pulmonary arteries were

279 ft in our understanding of vascular-resident endothelial progenitors in tissue regeneration opens new

280 mobilized microparticles prolong survival of endothelial progenitors in vitro and in vivo by downregu

281 We here aimed to define vessel-resident endothelial progenitors in vivo in a variety of tissues

282 Furthermore, we find that endothelial progenitors in which Notch is activated are

283 Moreover, transfer of purified BM endothelial progenitors instead of whole BM cells sustai

284 ing VEGFR2 inhibits the maturation of tumour endothelial progenitors into endothelium but not the dif

285 promoting premature release of KSHV-infected endothelial progenitors into the circulation.

286 Although purified HSPCs acquired endothelial progenitor markers once recruited to the kid

287 Therapies designed to mobilize endothelial progenitors or to increase their ability to

288 ESA induced greater chemotaxis of endothelial progenitor stem cells compared with saline (

289 y designed peptide ESA induces chemotaxis of endothelial progenitor stem cells, stimulates neovasculo

290 mediate proangiogenic functions ascribed to endothelial progenitors such as ECFCs in vivo and may be

291 markably, rQT3 treatment reduced circulating endothelial progenitors, suggesting virus-mediated antiv

292 tion is due to repair of injured LSECs by BM endothelial progenitors that engraft but fail to fully m

293 proangiogenic precursors and tissue-resident endothelial progenitors to vascular remodeling in IPAH.

294 iciently differentiate into CD34 (+ )CD31(+) endothelial progenitors upon GSK3 inhibition, female hPS

295 echanisms, de novo formation of vessels from endothelial progenitors (vasculogenesis) and sprouting o

296 t the differentiation of CD133(+) cells into endothelial progenitors, whereas gamma-secretase inhibit

297 resulted in a fraction expressing markers of endothelial progenitors while another fraction expressed

298 Thus, myo-endothelial progenitors with functioning Bmpr1a signalli

299 to identity the origin of endothelial progenitors within the hematopoietic hierarc

300 endothelial cells by limiting the number of endothelial progenitors within the mesoderm, probably fu